Ghost Tree Capital as of March 31, 2020
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 47 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| SPDR S&P Biotech (XBI) | 15.1 | $57M | 738k | 77.44 | |
| Spdr S&p 500 Etf (SPY) | 10.0 | $38M | 147k | 257.75 | |
| Invesco Qqq Trust Series 1 (QQQ) | 8.8 | $33M | 174k | 190.40 | |
| Health Care SPDR (XLV) | 5.7 | $22M | 245k | 88.58 | |
| Constellation Pharmceticls I | 5.4 | $20M | 650k | 31.43 | |
| Ascendis Pharma A S (ASND) | 4.5 | $17M | 150k | 112.61 | |
| Immunomedics | 3.8 | $14M | 1.1M | 13.48 | |
| Adverum Biotechnologies | 3.4 | $13M | 1.3M | 9.77 | |
| Axsome Therapeutics (AXSM) | 3.4 | $13M | 215k | 58.83 | |
| Mersana Therapeutics (MRSN) | 3.1 | $12M | 2.0M | 5.83 | |
| Immunovant (IMVT) | 2.9 | $11M | 710k | 15.56 | |
| Momenta Pharmaceuticals | 2.9 | $11M | 400k | 27.20 | |
| Iovance Biotherapeutics (IOVA) | 2.8 | $11M | 350k | 29.93 | |
| Rocket Pharmaceuticals (RCKT) | 2.4 | $9.1M | 650k | 13.95 | |
| Mirati Therapeutics | 2.3 | $8.8M | 115k | 76.87 | |
| Reata Pharmaceuticals Inc Cl A | 1.9 | $7.2M | 50k | 144.34 | |
| Aurinia Pharmaceuticals (AUPH) | 1.5 | $5.8M | 400k | 14.51 | |
| Fate Therapeutics (FATE) | 1.3 | $5.0M | 225k | 22.21 | |
| Myovant Sciences | 1.2 | $4.4M | 585k | 7.55 | |
| Selecta Biosciences (RNAC) | 1.1 | $4.2M | 1.7M | 2.41 | |
| BioCryst Pharmaceuticals (BCRX) | 1.1 | $4.0M | 2.0M | 2.00 | |
| Verastem | 1.1 | $4.0M | 1.5M | 2.64 | |
| Zogenix | 1.0 | $3.7M | 150k | 24.73 | |
| Xenon Pharmaceuticals (XENE) | 1.0 | $3.7M | 325k | 11.34 | |
| Trillium Therapeutics, Inc. Cmn | 0.9 | $3.3M | 825k | 4.04 | |
| Arvinas Ord (ARVN) | 0.9 | $3.2M | 80k | 40.30 | |
| Homology Medicines | 0.8 | $3.1M | 200k | 15.54 | |
| Iveric Bio | 0.8 | $2.8M | 829k | 3.44 | |
| Flamel Technologies Sa (AVDL) | 0.7 | $2.8M | 350k | 7.94 | |
| Syndax Pharmaceuticals (SNDX) | 0.7 | $2.7M | 250k | 10.97 | |
| Kalvista Pharmaceuticals (KALV) | 0.7 | $2.7M | 350k | 7.65 | |
| Satsuma Pharmaceuticals Ord | 0.7 | $2.5M | 115k | 21.52 | |
| Coherus Biosciences (CHRS) | 0.6 | $2.4M | 150k | 16.22 | |
| Invesco Currencyshares Euro Trust etf (FXE) | 0.6 | $2.2M | 21k | 104.32 | |
| Tg Therapeutics (TGTX) | 0.5 | $2.0M | 200k | 9.84 | |
| Viewray (VRAYQ) | 0.5 | $2.0M | 783k | 2.50 | |
| Sage Therapeutics (SAGE) | 0.5 | $1.9M | 65k | 28.72 | |
| Cue Biopharma (CUE) | 0.5 | $1.8M | 125k | 14.19 | |
| Kiniksa Pharmaceuticals (KNSA) | 0.5 | $1.7M | 113k | 15.48 | |
| Phasebio Pharmaceuticals (PHASQ) | 0.4 | $1.6M | 497k | 3.31 | |
| Protagonist Therapeutics (PTGX) | 0.4 | $1.6M | 228k | 7.06 | |
| Kadmon Hldgs | 0.4 | $1.5M | 350k | 4.19 | |
| Orchard Therapeutics Plc ads | 0.4 | $1.3M | 178k | 7.53 | |
| Applied Genetic Technol Corp C | 0.3 | $1.2M | 373k | 3.28 | |
| Biogen Idec (BIIB) | 0.3 | $1.0M | 3.3k | 316.31 | |
| Amarin Corporation (AMRN) | 0.2 | $662k | 166k | 4.00 | |
| Milestone Pharmaceuticals (MIST) | 0.1 | $384k | 209k | 1.84 |
